Abstract：OBJECTIVE: To study the perioperative change in serum neutrophil gelatinase-associated lipocalin (NGAL) level among children with congenital heart disease (CHD) and pulmonary hypertension (PH) and its significance. METHODS: Eighty children with CHD were divided into four groups according to pulmonary artery systolic pressure: non-PH, mild PH, moderate PH and severe PH groups. Serum NGAL levels were measured before operation, immediately after operation and 24 hours after operation. The relationship of serum NGAL level with PH and early prognosis was analyzed. RESULTS: The mild, moderate and severe PH groups had significantly higher serum NGAL levels than the non-PH group, and the severer the PH, the higher the serum NGAL level (P<0.01). All groups showed significant decreases in serum NGAL levels after operation (P<0.01). Serum NGAL level was positively correlated with the degree of PH and length of stay in the intensive care unit (P<0.01). CONCLUSIONS: Serum NGAL level increases in children with CHD and PH, and it gradually decreases after operation for closing the abnormal shunt. Serum NGAL level may be used as a serological indicator for evaluating the degree of PH and surgical outcome.
LIANG Yuan-Yuan,YE Jian-Rong,MA Hai-Ping et al. Perioperative change in serum neutrophil gelatinase-associated lipocalin level among children with congenital heart disease and pulmonary hypertension[J]. CJCP, 2013, 15(10): 827-830.
Friedl A, Stoesz SP, Buckley P, Gould MN. Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression[J]. Histoehem J, 1999, 31(7): 433-441.
[2]
Hemdahl AI, Gabrielsen A, Zhu C, Eriksson P, Hedin U, Kastrup J, et al. Expression of neutrophil gelatinase-assoeiated lipocalin in atherosclerosis and myocardial infarction[J]. Arterioscler Thromb Vasc Biol, 2006, 26(1): 136-142．
[3]
Inoue H, Ohga S, Kusuda T, Kitajima J, Kinjo T, Ochiai M, et al. Serum neutrophil gelatinase-associated lipocalin as a predictor of the development of bronchopulmonary dysplasia in preterm infants[J]. Early Hum Dev, 2013, 89(6): 425-429.
[4]
Eagan TM, Damas JK, Ueland T, Kitajima J, Kinjo T, Ochiai M, et al. Neutrophil gelatinase-associated lipocalin: A biomarker in COPD[J]. Chest, 2010, 138(4): 888-895.
[5]
Zhang PX, Chang JX, Xie JJ, Yuan HM, DU ZP, Zhang FR, et al. Regulation of neutrophil gelatinase-associated lipocalin expression by C/EBPβ in lung carcinoma cells[J]. Oncol Lett, 2012, 4(5): 919-924.
[6]
Mc Quillan BM, Picard MH, Leavitt M, Yuan HM, DU ZP, Zhang FR , et al. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects[J]. Circulation, 2001, 104(23): 2797-2802.
[7]
Duffels MG, Engelfriet PM, BergerRM, van Loon RL, Hoendermis E, Vriend JW, et al. Pulmonary arterial hypertension in congenital heart disease : an epidemiologic perspective from a Dutch registry[J]. Int J Cardiol, 2007, 120(2): 198-204.
[8]
Kjeldsen L, Johnsen AH, Sengelcv H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase[J]. J Biol Chem, 1993, 268(14): 10425-10432.
[9]
Cruz DN, Gaiao S, Maisel A, Ronco C, Devarajan P. Neutrophil gelatinase-associated lipocalin as a bio- marker of cardiovascular disease: a systematic review[J]. Clin Chem Lab Med, 2012, 50(9): 1533-1545.
[10]
Li Y, Zheng J, Bird IM, Magness RR. Effects of pulsatile shear stress on signaling mechanisms controlling nitric oxide production, endothelial nitric oxide synthase phosphorylation, and expression in ovine fetoplacental artery endothelial cells[J]. Endothelium, 2005, 12(1-2): 21-39.
[11]
Roudkenar MH, Kuwahara Y, Baba T, Roushandeh AM, Ebishima S, Abe S, et al. Oxidative stress induced lipocatin 2 gene expression: addressing its expression under the harmful conditions[J]. J Radiat Res, 2007, 48(1): 39-44.
[12]
Wang Y, Lam KS, Kraegen EW, Sweeney G, Zhang J, Tso AW, et al. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans[J]. Clin Chem, 2007, 53(1): 34-41.
[13]
Aigner F, Maierti T, Schwelberger HG, Wallnofer EA, Amberger A, Obrist P, et al. Lipoealin-2 regulates the inflammatory response during ischemia and reperfusion of the transplanted heart[J]. Am J Transplant, 2007, 7(4): 779-788.
